Proteolytic regulatory mechanism of chemerin bioactivity

Acta Biochimica et Biophysica Sinica

Volumn 41, Issue 12, 2009, Pages 973-979

  Du, Xiao Yan ^a   Leung, Lawrence L K ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Chemerin; Chemotactic; Inflammation; Proteolysis

Indexed keywords

BIOLOGICAL FACTOR; CHEMOKINE; CHEMOKINE RECEPTOR; ENZYME ACTIVATOR; PEPTIDE HYDROLASE;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CHEMISTRY; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PHYSIOLOGY;

AMINO ACID SEQUENCE; ANIMALS; BIOLOGICAL FACTORS; CHEMOKINES; ENZYME ACTIVATORS; HUMANS; INFLAMMATION; MOLECULAR SEQUENCE DATA; PEPTIDE HYDROLASES; RECEPTORS, CHEMOKINE;

EID: 71949124476     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmp091     Document Type: Article

References (44)

1. Nagpal S, Patel S, Jacobe H, DiSepio D, Ghosn C, Malhotra M and Teng M, et al. Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. J Investig Dermatol 1997, 109: 91-95.
2. Wittamer V, Franssen JD, Vulcano M, Mirjolet JF, Le Poul E, Migeotte I and Brézillon S, et al. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med 2003, 198: 977-985.
3. Meder W, Wendland M, Busmann A, Kutzleb C, Spodsberg N, John H and Richter R, et al. Characterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23. FEBS Lett 2003, 555: 495-499.
4. Zabel BA, Silverio AM and Butcher EC. Chemokine-like receptor 1 expression and chemerin-directed chemotaxis distinguish plasmacytoid from myeloid dendritic cells in human blood. J Immunol 2005, 174: 244-251.
5. Zabel BA, Zuniga L, Ohyama T, Allen SJ, Cichy J, Handel TM and Butcher EC. Chemoattractants, extracellular proteases, and the integrated host defense response. Exp Hematol 2006, 34: 1021-1032.
6. Du XY, Zabel BA, Myles T, Allen SJ, Handel TM, Lee PP and Butcher EC, et al. Regulation of chemerin bioactivity by plasma carboxypeptidase N, carboxypeptidase B (activated thrombin-activable fibrinolysis inhibitor), and platelets. J Biol Chem 2009, 284: 751-758.
7. Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, Collier G and Walder K, et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007, 148: 4687-4694.
8. Goralski KB, McCarthy TC, Hanniman EA, Zabel BA, Butcher EC, Parlee SD and Muruganandan S, et al. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem 2007, 282: 28175-28188.
9. Roh SG, Song SH, Choi KC, Katoh K, Wittamer V, Parmentier M and Sasaki S. Chemerin-a new adipokine that modulates adipogenesis via its own receptor. Biochem Biophys Res Commun 2007, 362: 1013-1018.
10. Albanesi C, Scarponi C, Pallotta S, Daniele R, Bosisio D, Madonna S and Fortugno P, et al. Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. J Exp Med 2009, 206: 249-258.
11. Zabel BA, Allen SJ, Kulig P, Allen JA, Cichy J, Handel TM and Butcher EC. Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades. J Biol Chem 2005, 280: 34661-34666.
12. Guillabert A, Wittamer V, Bondue B, Godot V, Imbault V, Parmentier M and Communi D. Role of neutrophil proteinase 3 and mast cell chymase in chemerin proteolytic regulation. J Leukoc Biol 2008, 84: 1530-1538.
13. Proost P, Mortier A, Loos T, Vandercappellen J, Gouwy M, Ronsse I and Schutyser E, et al. Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties. Blood 2001, 98: 3554-3561.
14. Proost P, Menten P, Struyf S, Schutyser E, De Meester I and Van Damme J. Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78beta into a most efficient monocyte attractant and CCR1 agonist. Blood 2000, 96: 1674-1680.
15. Matthews KW, Mueller-Ortiz SL and Wetsel RA. Carboxypeptidase N: A pleiotropic regulator of inflammation. Mol Immunol 2004, 40: 785-793.
16. Leung LL, Nishimura T and Myles T. Regulation of tissue inflammation by thrombin-activatable carboxypeptidase B (or TAFI). Adv Exp Med Biol 2008, 632: 61-69.
17. Balabanian K, Lagane B, Infantino S, Chow KY, Harriague J, Moepps B and Arenzana-Seisdedos F, et al. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem 2005, 280: 35760-35766.
18. Kucia M, Reca R, Miekus K, Wanzeck J, Wojakowski W, Janowska-Wieczorek A and Ratajczak J, et al. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: Pivotal role of the SDF-1-CXCR4 axis. Stem Cells 2005, 23: 879-894.
19. Broxmeyer HE. Regulation of hematopoiesis by chemokine family members. Int J Hematol 2001, 74: 9-17.
20. Burger JA and Peled A. CXCR4 antagonists: T argeting the microenvironment in leukemia and other cancers. Leukemia 2009, 23: 43-52.
21. Zlotnik A. New insights on the role of CXCR4 in cancer metastasis. J Pathol 2008, 215: 211-213.
22. Proost P, Struyf S, Schols D, Durinx C, Wuyts A, Lenaerts JP and De Clercq E, et al. Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1 alpha. FEBS Lett 1998, 432: 73-76.
23. Valenzuela-Fernández A, Planchenault T, Baleux F, Staropoli I, Le-Barillec K, Leduc D and Delaunay T, et al. Leukocyte elastase negatively regulates stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4. J Biol Chem 2002, 277: 15677-15689.
24. McQuibban GA, Butler GS, Gong JH, Bendall L, Power C, Clark-Lewis I and Overall CM. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem 2001, 276: 43503-43508.
25. Delgado MB, Clark-Lewis I, Loetscher P, Langen H, Thelen M, Baggiolini M and Wolf M. Rapid inactivation of stromal cell-derived factor-1 by cathepsin G associated with lymphocytes. Eur J Immunol 2001, 31: 699-707.
26. Davis DA, Singer KE, De La Luz Sierra M, Narazaki M, Yang F, Fales HM and Yarchoan R, et al. Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1alpha in the circulation. Blood 2005, 105: 4561-4568.
27. De La Luz Sierra M, Yang F, Narazaki M, Salvucci O, Davis D, Yarchoan R and Zhang HH, et al. Differential processing of stromalderived factor-1alpha and stromal-derived factor-1beta explains functional diversity. Blood 2004, 103: 2452-2459.
28. Wittamer V, Grégoire F, Robberecht P, Vassart G, Communi D and Parmentier M. The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency. J Biol Chem 2004, 279: 9956-9962.
29. Cash JL, Hart R, Russ A, Dixon JP, Colledge WH, Doran J and Hendrick AG, et al. Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J Exp Med 2008, 205: 767-775.
30. Wittamer V, Bondue B, Guillabert A, Vassart G, Parmentier M and Communi D. Neutrophil-mediated maturation of chemerin: A link between innate and adaptive immunity. J Immunol 2005, 175: 487-493.
31. Myles T, Nishimura T, Yun TH, Nagashima M, Morser J, Patterson AJ and Pearl RG, et al. Thrombin activatable fibrinolysis inhibitor, a potential regulator of vascular inflammation. J Biol Chem 2003, 278: 51059-51067.
32. Kulig P, Zabel BA, Dubin G, Allen SJ, Ohyama T, Potempa J and Handel TM, et al. Staphylococcus aureus-derived staphopain B, a potent cysteine protease activator of plasma chemerin. J Immunol 2007, 178: 3713-3720.
33. Parolini S, Santoro A, Marcenaro E, Luini W, Massardi L, Facchetti F and Communi D, et al. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 2007, 109: 3625-3632.
34. Vermi W, Riboldi E, Wittamer V, Gentili F, Luini W, Marrelli S and Vecchi A, et al. Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. J Exp Med 2005, 201: 509-515.
35. Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S and Yang R, et al. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 2005, 201: 713-722.
36. Samson M, Edinger AL, Stordeur P, Rucker J, Verhasselt V, Sharron M and Govaerts C, et al. Chem R 23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains. Eur J Immunol 1998, 28: 1689-1700.
37. Martensson UE, Fenyo EM, Olde B and Owman C. Characterization of the human chemerin receptor-ChemR23/CMKLR1-as co-receptor for human and simian immunodeficiency virus infection, and identification of virus-binding receptor domains. Virology 2006, 355: 6-17.
38. Barnea G, Strapps W, Herrada G, Berman Y, Ong J, Kloss B and Axel R, et al. The genetic design of signaling cascades to record receptor activation. Proc Natl Acad Sci USA 2008, 105: 64-69.
39. Zabel BA, Nakae S, Zúniga L, Kim JY, Ohyama T, Alt C and Pan J, et al. Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis. J Exp Med 2008, 205: 2207-2220.
40. Yoshimura T and Oppenheim JJ. Chemerin reveals its chimeric nature. J Exp Med 2008, 205: 2187-2190.
41. Skrzeczyńska-Moncznik J, Wawro K, Stefańska A, Oleszycka E, Kulig P, Zabel BA and Sukowski M, et al. Potential role of chemerin in recruitment of plasmacytoid dendritic cells to diseased skin. Biochem Biophys Res Commun 2009, 380: 323-327.
42. Fernandez-Ranvier GG, Weng J, Yeh RF, Khanafshar E, Suh I, Barker C and Duh QY, et al. Identification of biomarkers of adrenocortical carcinoma using genomewide gene expression profiling. Arch Surg 2008, 143: 841-846.
43. Zheng Y, Luo S, Wang G, Peng Z, Zeng W, Tan S and Xi Y, et al. Downregulation of tazarotene induced gene-2 (TIG2) in skin squamous cell carcinoma. Eur J Dermatol 2008, 18: 638-641.
44. Mohr S, Bottin MC, Lannes B, Neuville A, Bellocq JP, Keith G and Rihn BH. Microdissection, mRNA amplification and microarray: A study of pleural mesothelial and malignant mesothelioma cells. Biochimie 2004, 86: 13-19.